Research article · 2014
Conference abstractPublished 6 Jan 2014
Decrease in hepatic Mg2+ content promotes cortisol production in liver cells: Implications for the metabolic syndrome onset
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Metabolic syndrome, also known as Syndrome X, is a pathological condition affecting approximately 25% of the USA population. The condition is characterized by obesity, insulin resistance, and various degrees of hypertension. Metabolic syndrome is considered as the single most common condition predisposing to the development of various chronic diseases including diabetes and hypertension. Hypomagnesaemia has been consistently observed in association with metabolic syndrome, but it is unclear whether reduced Mg 2+ levels arethe consequence or a possible cause for the development of the metabolic syndrome and/or its associated pathologies. Recent research in our laboratory indicates that low Mg 2+ level in the circulation and within the hepatocytes promotesdysmetabolic conditions typical of the metabolic syndrome. Rats exposed for 2 weeks to a 40% Mg 2+ deficient diet present a 2-3 fold increase in intrahepatic triglyceride content, SREBP1c activation, PPAR γ upregulation, decreased glucose accumulation, and attenuated insulin signaling. Reduced intrahepatic total and free Mg 2+ content stimulates glucose 6-phosphate (G6Pi) transport into the endoplasmic reticulum (ER) and results in enhanced G6Pi hydrolysis by the glucose 6 phosphatase (G6Pase). More importantly, the increased G6Pi transport results in an enhanced conversion of G6Pi to 6-phosphogluconolactone by the glucose 6 phosphate dehydrogenase (G6PD), with generation of higher than normal intraluminal NADPH level. This pyridine nucleotide pool is utilized in several intraluminal processes including the conversion of cortisone to cortisol by the 11- β -hydroxysteroid dehydrogenase type 1 (11- β -OHSD1). In fact, we observed a significant, inverse correlation between hepatic Mg 2+ content and cortisol production. Taken together, our results provide compelling evidence that reduced extracellular Mg 2+ level precedes and promotes metabolic syndrome onset in that: 1) liver metabolism undergoes a switch from glucose-based to fatty acid-based metabolism, with increased deposition of intrahepatic triglycerides; 2) increased cortisol production, and 3) reduced insulin responsiveness. Work is currently in progress to determine whether restoration of normal extracellular or dietary Mg 2+ content renormalizes hepatic Mg 2+ content, and returns the mentioned metabolic processes to physiological levels, and whether our observation can be exported to other liver-based diseases such as alcoholic and non-alcoholic liver steatosis and steatohepatitis.
Subjects
Obesity & Weight ManagementAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 16 Oct 2015
Changes in liver metabolism in Mg2+ deficiency: Implications for NAFLD and metabolic syndrome
Conference abstract · 24 Jan 2017
Mg2+ deficiency results in increased intra-hepatic cortisol production through the H6PD/11-Ã?²-HSD1 machinery: Role of NF-kB and inflammatory cytokines
Conference abstract · 8 Dec 2016
Mg2+ deficiency results in increased intra-hepatic cortisol production through the H6PD/11- β-HSD1 machinery: Role of NF-kB and inflammatory cytokines
Conference abstract · 2 Nov 2015
Increased cortisol production through the H6PD/11-β-HSD1 machinery in Mg2+ deficient liver cells: Role of NF-kB and inflammatory cytokines
More from this journal
The newest in Journal of Obesity & Weight Loss Therapy.
Mini review · 13 Apr 2026
Semaglutide in the Real World: Bridging Effectiveness and Clinical Feasibility Through Flexible Dose Titration
Research article · 27 Feb 2026
Modulation of Postprandial GLP-1 Secretion and Glycemic Responses by a Food-Grade GLP-1 Formula in Human Subjects
Short communication · 9 Feb 2026
Intensive Blood Pressure Lowering Target Guided by Home Blood Pressure Monitoring for Hypertensive Patients with Type 2 Diabetes, Which is Better or Not
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Obesity & Weight Loss Therapy
- SubjectObesity & Weight Management
- BylineArticles whose byline prints “Andrea Romani”
- BylineArticles whose byline prints “Chesinta Voma”
- BylineArticles whose byline prints “Danial Amir Soltani”
- BylineArticles whose byline prints “Coleen Croniger”
